HQY vs. COLL

In the year-to-date period, HQY achieves a 3.19% return, which is significantly higher than COLL's 0.73% return. Over the past 10 years, HQY has outperformed COLL with an annualized return of 14.31%, while COLL has yielded a comparatively lower 5.20% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for HealthEquity, Inc. (HQY) and Collegium Pharmaceutical, Inc. (COLL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current HQY Sharpe Ratio is 0.59, which is higher than the COLL Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of HQY and COLL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither HQY nor COLL has paid dividends to shareholders.

The maximum HQY drawdown since its inception was -60.65%, smaller than the maximum COLL drawdown of -73.59%. Use the drawdown chart below to compare losses from any high point for HQY and COLL.

HealthEquity, Inc. (HQY) and Collegium Pharmaceutical, Inc. (COLL) have volatilities of 9.75% and 9.58%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between HealthEquity, Inc. and Collegium Pharmaceutical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.